Effect of Reversal of Neuromuscular Blockade on the Amplitude of Motor Evoked Potentials: A Randomized Controlled Cross Over Study Comparing Sugammadex and Placebo
Phase of Trial: Phase IV
Latest Information Update: 16 Oct 2018
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 09 Oct 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Aug 2019.
- 13 Apr 2018 Status changed from not yet recruiting to recruiting.
- 05 Feb 2018 Planned end date changed from 1 Sep 2018 to 1 Sep 2019.